“Is the efflux pump inhibitor Verapamil a potential booster for isoniazid against Mycobacterium tuberculosis?”, Braz. J. Pharm. Sci., vol. 56, p. e18309 , Dec. 2020, doi: 10.1590/s2175-97902020000218309.